Biomanufacturing Media
-
Addressing The Challenges Of LNP Upscaling
11/20/2025
Overcome LNP upscaling challenges by leveraging fluid mechanical principles. Learn how Impingement Jets Mixing achieves reproducible turbulence and consistent LNP quality across all production scales.
-
Lessons In Scaling Regenerative Medicine Manufacturing With Organogenesis's Patrick Bilbo
11/18/2025
In this episode of "Better Biopharma," Tyler Menichiello is joined by Patrick Bilbo, chief operating officer at Organogenesis, a regenerative medicine company developing and manufacturing advanced wound care products.
-
Accelerate Your pDNA And mRNA Process Development
11/13/2025
Explore a structured approach to optimizing and scaling plasmid DNA production using E. coli, with insights into key growth parameters, benchtop feasibility, and pilot-scale performance.
-
Biopharma Supply, Reimagined: Blarney, A Climate-Neutral Facility For Best-In-Class Filters
11/11/2025
Explore how a new, climate-neutral manufacturing facility strengthens biopharma supply chains. Understand the benefits of its advanced filtration technologies and commitment to environmental sustainability.
-
Transforming Nanoparticle Formulations From Bench To Commercial Scale
11/11/2025
Unlock seamless transition from lab-scale nanoparticle research to commercial production. Learn how scalable turbulent-jet mixing ensures precise, uniform, and reproducible formulation results.
-
Supply Chain Efficiency And Sourcing In Gene Therapy
11/4/2025
An overview of the inbound supply chain in gene therapy and the process development challenges that are frequently faced. Learn about concepts such as scaling, cell culture media sourcing, mixing technologies, and configurable packaging.
-
The Case For Optimized And Excipient GMP Cell Culture Solutions
10/27/2025
Learn how optimized, customizable formulations and Excipient GMP manufacturing streamline development, ensuring quality and consistency for a de-risked path to the clinic.
-
CMC Challenges Facing Next-Generation ADCs
10/22/2025
In this segment from the Bioprocess Online Live event “Evolving CMC Strategies To Enable Next-Gen ADCs,” panelists Michael Torres, Ph.D. (CrossBridge Bio), Morris Rosenberg, Ph.D. (CrossBridge Bio), and Borys Shor, Ph.D. (OS Therapies and Manhattan BioSolutions) weigh in on the biggest challenges to ADC development, particularly navigating geopolitical tensions in a time of increasingly global manufacturing operations.
-
Advancing Allogeneic Cell Therapy for SCI and Blindness with Lineage's Brian Culley
10/22/2025
On episode 114 of Cell & Gene: The Podcast, Host Erin Harris talks to Brian Culley, CEO of Lineage Cell Therapeutics, about advancing cell therapy beyond oncology and into transformative treatments for conditions such as spinal cord injury and blindness.
-
Selective Degradation Of Cancer Target WDR5
10/17/2025
Explore how to enable precise biophysical characterization of PROTACs targeting WDR5 to help overcome challenges with undruggable cancer proteins and complex interactions.